SUN PHARMA Q2 FY27 (CONS.) ; NET PROFIT DOWN 36.22% AT ₹1,988.53 CR (YOY), DOWN 31.31% (QOQ)

REVENUE UP 11.88% AT ₹16,198.71 CR (YOY), UP 5.87% (QOQ) EBITDA UP 4.79% AT ₹4,743.89 CR (YOY), UP 7.38% (QOQ) MARGINS AT 29.29% VS 31.27% (YOY), 28.87% (QOQ)

SUN PHARMA ADV.RES.CO.LTD

← Back to feed